Marksans Pharma Ltd's manufacturing facility at Verna, Goa approved by Australian TG

Marksans Pharma Limited (Reuters: MARK.BO; Bloomberg: MRKS IN; NSE: MARKSANS; BSE: 524404) hereby announces that its manufacturing facility located at Plot A-1, Phase 1-A, Verna Industrial Estate, Verna, Goa has been approved by Australian TGA for manufacture of pharmaceutical formulations in Solid Dosage Forms of Tablets and hard Capsules for Australian markets.

The products will be manufactured at the above facility in Goa India and marketed & distributed in Australian markets through the Company's subsidiary Nova Pharmaceuticals Australasia Pty Ltd.

Shares of Marksans Pharma Limited was last trading in BSE at Rs. 207.00 as compared to the previous close of Rs. 202.85. The total number of shares traded during the day was 144015 in over 2464 trades.

The stock hit an intraday high of Rs. 208.70 and intraday low of 203.50. The net turnover during the day was Rs. 29754481.00.

Source : Equity Bulls

Keywords

MarksansPharma INE750C01026 ManufacturingFacility Verna Goa AustralianTGA Approval